medigraphic.com
Instituto Nacional de Salud Pública

2013, Number 6

<< Back Next >>

salud publica mex 2013; 55 (6)

Sweetened beverages intake, hyperuricemia and metabolic syndrome. The Mexico City Diabetes Study

López-Molina R, Parra-Cabrera S, López-Ridaura R, González-Villalpando ME, Ferrannini E, González-Villalpando C

Language: English
References: 39
Page: 557-563
PDF size: 187.66 Kb.


ABSTRACT

Objective. To determine prevalence of hyperuricemia and its relation with intake of sweetened beverages (SB) and metabolic syndrome (MS) in low income urban Mexican population. Materials and methods. A cross-sectional analysis of The Mexico City Diabetes Study, a prospective population-based investigation (1 173 participants) was performed. We used logistic regression, adjusted by pertinent variables. We determined prevalence of hyperuricemia and explored associations of uric acid levels with MS and intake of SB. Results. Prevalence of hyperuricemia was 26.5 and 19.8% in males and females respectively. In an adjusted multivariate model, body mass index, waist circumference, and triglyceride were higher as uric acid quartiles increased (p‹0.005-0.001). The odds ratio for MS was 1.48 for 3rd uric acid quartile and 2.03 for 4th quartile. Higher consumption of SB was associated with higher uric acid levels (p‹0.001). Conclusion. Prevalence of hyperuricemia is high. Potential association with intake of SB, resulting in metabolic alterations should be considered.


REFERENCES

  1. Gagliardi AC, Miname MH, Santos RD. Uric acid: A marker of increased cardiovascular risk. Atherosclerosis 2009; 202:11-17.

  2. Rho YH, Zhu Y, Choi HK. The epidemiology of uric acid and fructose. Semin Nephrol 2011;31:410-419.

  3. Rivera JA, Muñoz-Hernández O, Rosas-Peralta M, Aguilar-Salinas CA, Popkin BM, Willett WC. [Beverage consumption for a healthy life: recommendations for the Mexican population]. Salud Publica Mex 2008;50:173-195.

  4. Quiñones-Galván A, Natali A, Baldi S, Frascerra S, Sanna G, Ciociaro D, et al. Effect of insulin on uric acid excretion in humans. Am J Physiol 1995;268: E1-5.

  5. Muscelli E, Natali A, Bianchi S, Bigazzi R, Galvan AQ, Sironi AM, et al. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens 1996;9:746-752.

  6. Perez-Pozo SE, Schold J, Nakagawa T, Sánchez-Lozada LG, Johnson RJ, Lillo JL. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes 2010;34:454-461.

  7. Marquez-Sandoval F, Macedo-Ojeda G, Viramontes-Horner D, Fernández Ballart JD, Salas- Salvadó J, et al. The prevalence of metabolic syndrome in Latin America: a systematic review. Public Health Nutr 2011;14:1702-1713.

  8. Barquera S, Campos-Nonato I, Hernández-Barrera L, Flores M, Durazo- Arvizu R, Kanter R, et al. Obesity and central adiposity in Mexican adults: results from the Mexican National Health and Nutrition Survey 2006. Salud Publica Mex 2009;51 (Suppl 4):S595-603.

  9. Aguilar-Salinas CA, Gómez-Pérez FJ, Rull J, Villalpando S, Barquera S, Rojas R. Prevalence of dyslipidemias in the Mexican National Health and Nutrition Survey 2006. Salud Publica Mex 2010; 52 (Suppl 1): S44-53.

  10. Ventura EE, Davis JN, Goran MI. Sugar content of popular sweetened beverages based on objective laboratory analysis: focus on fructose content. Obesity 2011;19:868-874.

  11. Encuesta Nacional de Ingresos y Gastos de los Hogares 2004. ENIGH. La Estructura, Distribución y Monto de los Ingresos de los Hogares 2004.[monografia en internet] Aguascalientes, Ags. Instituto Nacional de Estadística Geografía e Informática [consultado 2013 junio 4] Disponible en: http //www.inegi.gob.mx/prod.../encuestas/hogares/enigh/2004/ enigh_2004.pdf

  12. Stern MP, González-Villalpando C, Mitchell BD, Villalpando E, Haffner SM, Hazuda HP. Genetic and environmental determinants of type II diabetes in Mexico City and San Antonio. Diabetes 1992; 41: 484-492.

  13. Hunt KJ, González ME, Lopez R Haffner SM, Stern MP, González-Villalpando C. Diabetes is more lethal in Mexicans and Mexican-Americans compared to Non-Hispanic whites. Ann Epidemiol 2011; 21:899-906.

  14. Haffner S, González-Villalpando C, Hazuda H, Valdez R, Mykkänen L, Stern M. Prevalence of hypertension in Mexico City and San Antonio,Texas. Circulation 1994;90:1542-1549.

  15. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL , et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252.

  16. Hernández-Avila M, Romieu I, Parra S, Hernández-Avila J, Madrigal H, Willett W. Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud Publica Mex 1998;40:133-140.

  17. Stern MP, González-Villalpando C, Hernández M, Knapp JA, Hazuda HP, Villalpando E, et al. Performance of semiquantitative food frequency questionnaires in international comparisons. Mexico City versus San Antonio, Texas. Ann Epidemiol 1993;3:300-307.

  18. Millen BE, Quatromoni PA, Pencina M, Kimokoti R, Nam BH, Cobain S, et al. Unique dietary patterns and chronic disease risk profiles of adult men: The Framingham Nutrition Studies. J Am Diet Assoc 2005;105:1723-1734.

  19. Oeltgen PR, Welborn JR, Burgess MS. Evaluation of the Abbott Spectrum “High-Performance” Diagnostic System. Clin Chem 1988;34:180-181.

  20. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011; 63: 3136-3141.

  21. Alberti KG, Zimmet P, Shaw J , IDF Epidemiology Task Force Consensus Group. The metabolic syndrome--a new worldwide definition. Lancet 2005;366:1059-1062.

  22. Lanaspa MA, Tapia E, Soto V, Sautin Y, Sánchez-Lozada LG. Uric acid and fructose: potential biological mechanisms. Semin Nephrol 2011;31:426-432.

  23. Johnson RJ, Perez-Pozo SE, Sautin YY, Manitius J, Sanchez-Lozada LG, Feig DI, et al. Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev 2009;30:96-116.

  24. Teff KL, Grudziak J, Townsend RR, Dunn TN, Grant RW, Adams SH, et al. Endocrine and metabolic effects of consuming fructose- and glucosesweetened beverages with meals in obese men and women: Influence of insulin resistance on plasma triglyceride responses. J Clin Endocrinol Metab 2009;94:1562-1569.

  25. González-Chávez A, Elizondo-Argueta S, Amancio-Chassin O. Relación entre síndrome metabólico e hiperuricemia en población aparentemente sana. Rev Med Hosp Gen Mex 2011; 74:132-137.

  26. Reyes-Jiménez AE, Navarro J, Cruz IM, Castro DLJ, Landgrave GJ, Narváez PC, et al. Prevalencia del síndrome metabólico en relación con las concentraciones de ácido úrico. Med Int Mex 2009;25:278-284.

  27. Llamazares-Azuara L, Rodríguez-Martínez M, De la Cruz-Mendoza E, Torres Ruvalcaba A, Flores-Sánchez J. Prevalencia de hiperuricemia, resistencia a la insulina, obesidad y dislipidemias en jovenes de 17 a 23 años. Bioquimia 2007;32:134.

  28. Rodrigues SL, Baldo MP, Capingana P, Magalhães P, Dantas EM, Molina M del C, et al. Gender distribution of serum uric acid and cardiovascular risk factors: population based study. Arq Bras Cardiol 2012; 98: 13-21.

  29. Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 2007;120:442-447.

  30. Aguilar-Salinas CA, Rojas R, Gómez-Pérez FJ, Valles V, Ríos-Torres JM, Franco A, et al. High prevalence of metabolic syndrome in Mexico. Arch Med Res 2004;35: 76-81.

  31. Wen CP, David-Cheng TY, Chan HT, Tsai MK, Chung WS, Tsai SP, et al. Is high serum uric acid a risk marker or a target for treatment ? Examination of its independent effect in a large cohort with low cardiovascular risk. Am J Kidney Dis 2010;56:273-288.

  32. Obrador GT, Garcia-Garcia G, Villa AR, Rubilar X, Olvera N, Ferreira E, et al. Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) Mexico and comparison with KEEP US. Kidney Int Suppl 2010;116:S2-S8

  33. Haffner SM, González-Villalpando C, Valdez RA, Mykkänen L, Hazuda HP, Mitchell BD, et al. Is microalbuminuria part of the prediabetic state ? The Mexico City Diabetes Study. Diabetologia 1993;36:1002-1006.

  34. Jimenez-Corona A, Rivera-Martinez D, Hernandez-Avila M, Haffner S, Williams K, González-Villalpando ME, et al. Microalbuminuria as a predictor of myocardial infarction in a Mexican population: The Mexico City Diabetes Study. Kidney Int Suppl 2005;97:S34-S39.

  35. González-Villalpando C, Stern MP, González-Villalpando ME, Rivera MD, Simón J, Islas S, et al. The Mexico City Diabetes Study: A population based approach to the study genetic and environmental interactions in the pathogenesis of obesity and diabetes. Nutrition Reviews 1999;57:S71-S77.

  36. Hernández Avila M, González-Villalpando C, Palazuelos E, Hu H, González-Villalpando ME, Rivera Martínez D. Determinants of blood lead levels across the menopausal transition. Arch Environ Health 2000;55:355-360.

  37. Jiménez-Aguilar A, Flores M, Shamah-Levy T. Sugar-sweetened beverages consumption and BMI in Mexican adolescents: Mexican National Health and Nutrition Survey 2006. Salud Publica Mex 2009; 51 (Suppl 4):S604-612.

  38. Bomback AS1, Derebail VK, Shoham DA, Anderson CA, Steffen LM, Rosamond WD, et al. Sugar-sweetened soda consumption, hyperuricemia, and kidney disease. Kidney Int 2010;77:609-616.

  39. Cheng HT, Huang JW, Chiang CH, Yen CH, Hung KY, Wu KD. Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly. J Clin Endocrinol Metab 2012;97:1268-1276.




2020     |     www.medigraphic.com